Arkhjamil Angeles
- Microbiology top 5%
-
- Prostate Cancer Treatment and Research 7
- Gastric Cancer Management and Outcomes 2
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
-
- Cancer Genomics and Diagnostics 3
-
- Ubiquitin and proteasome pathways 2
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Jennifer L. BishopAmina ZoubeidiKim N.Morgan E. RobertsArun AzadAlexander W. WyattAlan M. SugarDong Lin
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)American Society of Clinical Oncology Educational Book (1 paper)
- Partner nations
- CanadaUnited StatesMexico
In The Last Decade
Arkhjamil Angeles
19 papers receiving 724 citations
Peers
Comparison fields: 5 of 67
- Microbiology 23
- Pulmonary and Respiratory Medicine 433
- Oncology 286
- Cancer Research 150
- Immunology 145
Countries citing papers authored by Arkhjamil Angeles
This map shows the geographic impact of Arkhjamil Angeles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arkhjamil Angeles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arkhjamil Angeles more than expected).
Fields of papers citing papers by Arkhjamil Angeles
This network shows the impact of papers produced by Arkhjamil Angeles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arkhjamil Angeles. The network helps show where Arkhjamil Angeles may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arkhjamil Angeles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2021 | 52 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 263 | |
| 12 | 2014 | 1 | |
| 13 | 2014 | 210 | |
| 14 | 2013 | 38 | |
| 15 | 2011 | 110 | |
| 16 | A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer. | 1996 | 1 |
| 17 | Malignant neoplasms in renal transplant patients: a 24-year experience. | 1992 | 4 |
| 18 | 1987 | 32 | |
| 19 | [Adenocarcinoma in situ and adenocarcinoid of the esophagus originating in Barrett's epithelium. Report of a case]. | 1987 | 2 |
About Arkhjamil Angeles
Arkhjamil Angeles is a scholar working on Microbiology, Transplantation and Oncology, having authored 19 papers that have together received 732 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (2 papers), Ubiquitin and proteasome pathways (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Microbiology (23 citations), Pulmonary and Respiratory Medicine (433 citations) and Oncology (286 citations). Arkhjamil Angeles has collaborated with scholars based in Canada, United States and Mexico. Frequent co-authors include Jennifer L. Bishop, Amina Zoubeidi, Kim N., Morgan E. Roberts, Arun Azad, Alexander W. Wyatt, Alan M. Sugar, Dong Lin, Ladan Fazli and Colin C. Collins. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, American Society of Clinical Oncology Educational Book, Frontiers in bioscience and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.